EMILY FRASER: Open Payments
NPI 1871224071 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 17 payments from 10 companies in 2025. Trend: 2023 $627 · 2024 $392 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 1 | $174 |
| SHIELD THERAPEUTICS INC | 4 | $86 |
| Sage Therapeutics, LLC | 3 | $50 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $40 |
| Lilly USA, LLC | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| MILLICENT US INC | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: CLOTTRIEVER BOLD CATHETER, ACCRUFER, ZURZUVAE, ZEPBOUND, MYFEMBREE, Veozah, Lynkuet, INTRAROSA.
Industry payments across KY — which companies pay providers there.
